International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 13 on Bulk Density and Tapped Density of Powders General Chapter; Availability; Correction, 43172 [2010-18119]

Download as PDF 43172 Federal Register / Vol. 75, No. 141 / Friday, July 23, 2010 / Notices EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST TO THE GOVERNMENT Cost component Annualized cost Total cost Project Management ................................................................................................................................ Project Development ............................................................................................................................... Data Collection and Analysis ................................................................................................................... Technical Assistance and Consultation ................................................................................................... Confirmatory lab testing ........................................................................................................................... Travel ....................................................................................................................................................... Project Supplies and materials ................................................................................................................ Overhead ................................................................................................................................................. $28,315 84,944 169,888 60,750 20,000 7,500 2,450 126,395 $56,629 169,400 339,776 121,500 40,000 15,000 4,900 252,790 Total .................................................................................................................................................. 499,998 999,995 Request for Comments In accordance with the above-cited Paperwork Reduction Act legislation, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ healthcare research and healthcare information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Dated: July 9, 2010. Carolyn M. Clancy, Director. DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Toxic Substances and Disease WReier-Aviles on DSKGBLS3C1PROD with NOTICES [FR Doc. 2010–18063 Filed 7–22–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 13 on Bulk Density and Tapped Density of Powders General Chapter; Availability; Correction BILLING CODE 4160–90–M AGENCY: Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ ATSDR): Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Board of Scientific Counselors, Agency for 15:15 Jul 22, 2010 Dated: July 15, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [Docket No. FDA–2010–D–0347] [FR Doc. 2010–17796 Filed 7–22–10; 8:45 am] VerDate Mar<15>2010 Toxic Substances and Disease Registry, of the Department of Health and Human Services, has been renewed for a 2-year period extending through May 21, 2012. For further information, contact Paula Burgess, M.D., Ph.D., Designated Federal Officer, BSC, NCEH/ATSDR, 1600 Clifton Road, NE, Mailstop E–28, Atlanta, Georgia 30333, telephone 404/ 488–0574, e-mail. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Jkt 220001 Food and Drug Administration, HHS. ACTION: Notice; correction. The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of July 14, 2010 (75 FR 40843). The document announced the availability of a draft guidance entitled ‘‘Q4B Evaluation and Recommendation SUMMARY: PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 of Pharmacopoeial Texts for Use in the ICH Regions; Annex 13: Bulk Density and Tapped Density of Powders General Chapter.’’ The document was published with an incorrect docket number. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Planning and Budget, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 3208, Silver Spring, MD 20993–0002, 301–796–9148. SUPPLEMENTARY INFORMATION: In FR Doc. 2010–17055, appearing on page 40843 in the Federal Register of Wednesday, July 14, 2010, the following correction is made: On page 40843, in the first column, in the headings section of the document, ‘‘[Docket No. FDA–2010–N–0344]’’ is corrected to read ‘‘[Docket No. FDA– 2010–D–0347]’’. Dated: July 20, 2010. David Dorsey, Acting Deputy Commissioner for Policy, Planning and Budget. [FR Doc. 2010–18119 Filed 7–22–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Administration for Children and Families Maternal, Infant, and Early Childhood Home Visiting Program Health Resources and Services Administration and Administration for Children and Families, HHS. ACTION: Request for public comment on criteria for evidence of effectiveness of home visiting program models for pregnant women, expectant fathers, and caregivers of children birth through kindergarten entry. AGENCY: The Health Resources and Services Administration and SUMMARY: E:\FR\FM\23JYN1.SGM 23JYN1

Agencies

[Federal Register Volume 75, Number 141 (Friday, July 23, 2010)]
[Notices]
[Page 43172]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18119]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-D-0347]


International Conference on Harmonisation; Draft Guidance on Q4B 
Evaluation and Recommendation of Pharmacopoeial Texts for Use in the 
International Conference on Harmonisation Regions; Annex 13 on Bulk 
Density and Tapped Density of Powders General Chapter; Availability; 
Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of July 14, 2010 (75 FR 40843). 
The document announced the availability of a draft guidance entitled 
``Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in 
the ICH Regions; Annex 13: Bulk Density and Tapped Density of Powders 
General Chapter.'' The document was published with an incorrect docket 
number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, 
Planning and Budget, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 32, rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.

SUPPLEMENTARY INFORMATION: In FR Doc. 2010-17055, appearing on page 
40843 in the Federal Register of Wednesday, July 14, 2010, the 
following correction is made:
    On page 40843, in the first column, in the headings section of the 
document, ``[Docket No. FDA-2010-N-0344]'' is corrected to read 
``[Docket No. FDA-2010-D-0347]''.

    Dated: July 20, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-18119 Filed 7-22-10; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.